SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-282819
Filing Date
2015-08-07
Accepted
2015-08-07 14:08:52
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d36656d10q.htm 10-Q 265345
2 EX-31.1 d36656dex311.htm EX-31.1 6000
3 EX-31.2 d36656dex312.htm EX-31.2 5982
4 EX-32.1 d36656dex321.htm EX-32.1 4084
5 EX-32.2 d36656dex322.htm EX-32.2 4060
  Complete submission text file 0001193125-15-282819.txt   2005028

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20150630.xml EX-101.INS 314836
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20150630.xsd EX-101.SCH 26273
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20150630_cal.xml EX-101.CAL 43201
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20150630_def.xml EX-101.DEF 63777
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20150630_lab.xml EX-101.LAB 221366
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20150630_pre.xml EX-101.PRE 153688
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 151036665
SIC: 2834 Pharmaceutical Preparations